PHGR: The Growing Threat of Multidrug-Resistant Gonorrhea

PHGR: The Growing Threat of Multidrug-Resistant Gonorrhea

If you missed the CDC Public Health Grand Rounds, entitled “The Growing Threat of Multidrug-Resistant Gonorrhea,” on May 15, you can now view the recording of the webinar.

This session of Grand Rounds explored the development of antibiotic resistance in Neisseria gonorrhoeae. Through the course of history, gonorrhea has progressively developed resistance to the drugs prescribed to treat it. This is a public health concern because the gonorrhea control strategy in the United States relies on effective antibiotic therapy. 

Given the ability of the gonorrhea bacterium to develop antibiotic resistance, it is critical to continuously monitor gonococcal antibiotic resistance and encourage research and development of new treatment regimens for gonorrhea.

CDC’s Public Health Grand Rounds Presents:
The Growing Threat of Multidrug-Resistant Gonorrhea
View Recording and Slides


Presented By:
Edward Hook III, MDProfessor of Medicine and Epidemiology
University of Alabama, Birmingham
“Neisseria Gonorrhoeae Infections and Antimicrobial Treatment: Public Health Context and Challenges”
William Shafer, PhDProfessor of Microbiology and Immunology
Emory University
“Molecular Basis of Resistance and Importance of the Laboratory in Detection of Resistance”

Carolyn Deal, PhDChief, Sexually Transmitted Diseases Branch
National Institute of Allergy and Infectious Diseases
National Institutes of Health
“Tools to Combat Multidrug Resistance”

Robert D. Kirkcaldy, MD, MPH Medical Officer
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
“What Public Health Can Do Now and in the Future”

Facilitated By:
Tanja Popovic, MD, PhD, Scientific Director, Public Health Grand Rounds
John Iskander, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Manager, Public Health Grand Rounds